Revolution Medicines · 3 hours ago
Associate Director, Analytics and Insights
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The Associate Director Analytics and Insights role requires strategic thinking and analytical expertise to provide critical contributions to brand strategy, launch and life-cycle planning, forecasting, and senior management decisions.
Health CareLife ScienceMedical
Responsibilities
Leads, designs, and executes primary market research projects with HCPs, patients, and payors
Initiates and facilitates activities that enhance colleagues’ knowledge regarding the relevant market and potential product attitudes, usage, market dynamics, and competition (for example, development of treatment flows, target product profiles, opportunity assessments, and market landscape research)
Shares the voice of the community (e.g., physicians, patients, payors) to the organization by maintaining and communicating a holistic understanding of the marketplace synthesized from primary and secondary sources
Communicates and aligns key internal stakeholders around market research and analytics objectives and outputs including qualifying the results based on the strength of the data and identifying limitations
Develops and presents timely final reports and actionable recommendations to key stakeholders, focusing on key findings and relevant implications to each stakeholder group, and senior leadership
Translates data and information into compelling insights and recommendations. Effectively communicates insights and leads meetings with commercial leaders and other cross-functional business partners
Shapes situation analysis as a part of launch planning to provide a comprehensive understanding of the market. Partner with cross-functional teams like marketing, sales (when appropriate), access, medical, and finance to provide a clear view of the market
Demonstrates the ability to quickly understand complex markets, disease states, competitive landscapes, and relevant market and managed care dynamics
Exhibits analytical rigor in the valuation of business opportunities and the quantification of risk
Participates in cross-functional teams to gather input for functional activities, and ensure alignment e.g., with clinical development, medical affairs, and investor relations
Delivers operating expenses within budget
Travels as needed
Other duties as assigned
Qualification
Required
Bachelor's degree required with 10+ years of progressive experience in a commercial function in the pharmaceutical or biotech industry or strategy consulting, and 4+ years of experience in strategic analysis, planning, and primary research
Experience in market development, new product launches, and competitive intelligence
Extensive primary research and secondary analytical skills required; ability to translate the data and learning into actionable recommendations for business growth
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business
Strong problem solver with experience leveraging a variety of research and analytical vendors, study designs, and building quality research vendor partnerships
Demonstrated ability to influence senior management and key business partners
Proven experience in a smaller, rapidly growing, company
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication
Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patients
Preferred
MBA with 6+ years of progressive experience in commercial pharmaceutical /biotech industry, and 4+ years of experience in strategic analysis, planning, and primary research
Targeted Oncology product experience strongly preferred
Experience developing launch and long-range forecasts
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase